Sun BioPharma, Inc. Announces Completion of the Fifth Patient Cohort in the Dose Escalation Phase 1a Study of SBP-101 for Pancreatic Cancer
Next Cohort of Patients Initiates Pathway to Determining Maximum Tolerated Dose (MTD) Summary Data of First Five Cohorts Show Efficacy […]